COPD
Pulmonary Fibrosis
Other lung diseases: cystic fibrosis, pulmonary hypertension

Chronic obstructive pulmonary disease (COPD) is a combination of inflammation and a thickening of airway walls that causes a narrowing and loss of their elasticity, which results in the progressive destruction of the alveoli in the lung (air sacs).

Approximately 12 million Americans are diagnosed with COPD and it’s estimated that there are10 million cases that are undiagnosed. COPD is the fourth cause of deaths in the US and a leading cause of mortality and disability worldwide.

The term COPD includes emphysema and chronic obstructive bronchitis. The most frequent cause for COPD is cigarette smoking. Long term exposure to chemicals fumes, pollution or dust may also contribute to the disease.

Pulmonary fibrosis is characterized by the replacement of the normal lung tissues by fibrotic tissue, scarring, and the irreversible destruction of the normal lung architecture that results in the inability to transfer oxygen into the bloodstream.

Clinical trials using mesenchymal stem cells for the treatment of lung diseases are promising for various types of pulmonary diseases. Pre-clinical studies on animals have shown that mesenchymal stem cells can potentially assist in the treatment of numerous lung diseases. Early studies suggest that stem cells work by repairing the lung tissue and possibly decreasing the local inflammation and regulation of the immune response.

Cell therapy is combined with a holistic comprehensive approach. The entire treatment takes five days to complete. Our program includes lifestyle and diet recommendations as well as personalized natural supplement prescriptions for respiratory and immune system support.

Patients are followed up at regular intervals with pulmonary function tests, and quality of life evaluation post stem cell therapy to monitor their progress.